BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37359050)

  • 61. Elevated SPINK2 gene expression is a predictor of poor prognosis in acute myeloid leukemia.
    Xue C; Zhang J; Zhang G; Xue Y; Zhang G; Wu X
    Oncol Lett; 2019 Sep; 18(3):2877-2884. PubMed ID: 31452767
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
    Li D; Yin Y; He M; Wang J
    Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).
    Quan J; Bai Y; Yang Y; Han EL; Bai H; Zhang Q; Zhang D
    BMC Cancer; 2021 Jul; 21(1):814. PubMed ID: 34266404
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Potential Molecular Mechanisms and Drugs for Aconitine-Induced Cardiotoxicity in Zebrafish through RNA Sequencing and Bioinformatics Analysis.
    Wang M; Shi Y; Yao L; Li Q; Wang Y; Fu D
    Med Sci Monit; 2020 Jun; 26():e924092. PubMed ID: 32598336
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV.
    Yan C; Niu Y; Wang X
    Front Immunol; 2022; 13():1008653. PubMed ID: 36389792
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of Biomarkers for Ovarian Cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
    Zheng Q; Ye H; Zhong H; Wang M
    Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of Hub Genes Associated with Progression and Prognosis of Bladder Cancer by Integrated Bioinformatics Analysis.
    Jiang S; Ma J; Wei S; Ren P; Liu J; Zhou Y; Liu D; Zhang X
    Arch Esp Urol; 2022 Nov; 75(9):779-790. PubMed ID: 36472061
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IRF8 and its related molecules as potential diagnostic biomarkers or therapeutic candidates and immune cell infiltration characteristics in steroid-induced osteonecrosis of the femoral head.
    Liang XZ; Liu XC; Li S; Wen MT; Chen YR; Luo D; Xu B; Li NH; Li G
    J Orthop Surg Res; 2023 Jan; 18(1):27. PubMed ID: 36627660
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bioinformatics-based identification of SPNS3 (Spinster homolog 3) as a prognostic biomarker of apoptosis resistance in acute myeloid leukemia.
    Hong Y; Tian X; Wang M; Chen C; Sun A
    Bioengineered; 2021 Dec; 12(1):7837-7848. PubMed ID: 34608834
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 74. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of six hub genes and analysis of their correlation with drug sensitivity in acute myeloid leukemia through bioinformatics.
    Cai D; Liang J; Cai XD; Yang Y; Liu G; Zhou F; He D
    Transl Cancer Res; 2021 Jan; 10(1):126-140. PubMed ID: 35116245
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia.
    Niu P; Yao B; Wei L; Zhu H; Fang C; Zhao Y
    Blood Cells Mol Dis; 2019 Jul; 77():43-50. PubMed ID: 30954792
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification and Analysis of Novel Biomarkers Involved in Chromophobe Renal Cell Carcinoma by Integrated Bioinformatics Analyses.
    Zhang W; Xu Y; Zhang J; Wu J
    Biomed Res Int; 2020; 2020():2671281. PubMed ID: 32090070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.